UnknownPhase 4NCT05498090
Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome
Studying Sex chromosome difference of sex development
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Colorado, Denver
- Principal Investigator
- Shanlee M Davis, MD, PhD, NPUniversity of Colorado, Denver
- Intervention
- Fenofibrate 145 mg(drug)
- Enrollment
- 44 enrolled
- Eligibility
- 15-40 years · MALE
- Timeline
- 2022 – 2025
Study locations (1)
- University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05498090 on ClinicalTrials.govOther trials for Sex chromosome difference of sex development
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07142135Long-term Systematic Follow-up of Patients With Klinefelter Syndrome Followed at the Department of Growth and Reproduction, RigshospitaletRigshospitalet, Denmark
- RECRUITINGPHASE4NCT06294990Klinefelter Syndrome and Testosterone Treatment in PubertyLise Aksglæde
See all trials for Sex chromosome difference of sex development →